Ion Boiangiu

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Effects of a self-managed home-based walking intervention on psychosocial health outcomes for breast cancer patients receiving chemotherapy: a randomised controlled trial

Kajal Gokal, Deborah J. Wallis, Samreen Ahmed et al. · Supportive Care in Cancer · 2015 · 110 citations · Full text

Nursing, Behavioral Medicine, Health Policy +7

Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol

Kajal Gokal, Fehmidah Munir, Deborah J. Wallis et al. · BMC Public Health · 2015 · 25 citations · Full text

Concomitant (without Adjuvant) Temozolomide and Radiation to Treat Glioblastoma: a Retrospective Study

T. Sridhar, A. Jesse Gore, Ion Boiangiu et al. · Clinical Oncology · 2008 · 18 citations · Full text

Retrospective Study, Neuro-oncology, Radiation Medicine +10